Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?

, &
American Journal of Bioethics 17 (4):66-67 (2017)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2017.1284934

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,571

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.Clark B. Hanmer & Adelaide Doussau - 2017 - American Journal of Bioethics 17 (4):68-69.
What Difference Does It Make to Be Treated in a Clinical Trial? A Pilot Study.Charles Weijer, Benjamin Freedman, Abraham Fuks, James Robbins, Stanley Shapiro & Myriam Skrutkowska - unknown
Ethical Considerations for Volunteer Recruitment of Visual Prosthesis Trials.Yu Xia & Qiushi Ren - 2013 - Science and Engineering Ethics 19 (3):1099-1106.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2012 - Bioethics 28 (3):138-146.
Informed consent in acute myocardial infarction research.Anne Gammelgaard - 2004 - Journal of Medicine and Philosophy 29 (4):417 – 434.
An intervention to improve cancer patients' understanding of early-phase clinical trials.Nancy E. Kass, Jeremy Sugarman, Amy M. Medley, Linda A. Fogarty, Holly A. Taylor, Christopher K. Daugherty, Mark R. Emerson, Steven N. Goodman, Fay J. Hlubocky & Herbert I. Hurwitz - 2009 - IRB: Ethics & Human Research 31 (3):1.
Clinical Trials and Scid Row: The Ethics of Phase 1 Trials in the Developing World.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128-135.
Clinical trials and scid row: The ethics of phase 1 trials in the developing world.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128–135.
The protection of patients' rights in clinical trials.Marek Czarkowski - 2006 - Science and Engineering Ethics 12 (1):131-138.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach.S. M. Madsen, S. Holm & P. Riis - 2007 - Journal of Medical Ethics 33 (4):234-240.
Starting clinical trials of xenotransplantation--reflections on the ethics of the early phase.S. Welin - 2000 - Journal of Medical Ethics 26 (4):231-236.
Evaluating the Risks and Benefits of Phase II and III Clinical Cancer Trials: A Look at Institutional Review Board Members in the Netherlands.H. van Luijn, A. Musschenga, R. Keus & N. Aaronson - 2007 - IRB: Ethics & Human Research 29 (1).
How to Resolve an Ethical Dilemma Concerning Randomized Clinical Trials.Don Marquis - unknown
Terminal illness and access to phase 1 experimental agents, surgeries and devices: Reviewing the ethical arguments.Udo Schüklenk & Christopher Lowry - 2009 - British Medical Bulletin 89 (1):7-22.

Analytics

Added to PP
2017-03-23

Downloads
16 (#900,320)

6 months
8 (#351,566)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Modern Pregnancies and (Im)Perfect Babies.Stephanie A. Kraft - 2017 - American Journal of Bioethics 17 (1):1-2.

Add more citations

References found in this work

No references found.

Add more references